Arkolith/Insider Trading/BDTX/Form 4

Epstein David M.

SEE REMARKS, DirectorBlack Diamond Therapeutics, Inc. (BDTX) · full profile →Form 4 · filed Jun 28, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$168K
Net Open-Market Flow
-$168K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 27, 2023Sell(S)25K$6.70$168K671K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-23-010388) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML